Two Sigma Advisers »

Maxcyte shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $106k 23k 4.70

More positions owned by Two Sigma Advisers

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Merck & Co (MRK)
Micron Technology (MU)
Netflix (NFLX)
Paypal Holdings (PYPL)
Bristol Myers Squibb (BMY)
Qualcomm (QCOM)
Pinterest Cl A (PINS)
Meta Platforms Cl A (META)
General Motors Company (GM)

View all positions for Two Sigma Advisers

Top funds holding Maxcyte

Cadian Capital Management
Vanguard Group
Vitruvian Partners
Millennium Management
Portolan Capital Management
Massachusetts Financial Services
Blue Water Life Science Advisors
River & Mercantile Asset Management
Arrowpoint Asset Management
Dimensional Fund Advisors
Willis Investment Counsel
Fred Alger Management
Roubaix Capital
Lazard Asset Management
Bank of New York Mellon

View all funds holding Maxcyte